Log In
BCIQ
Print this Print this
 

IBI-60089

  Manage Alerts
Collapse Summary General Information
Company Icon Bioscience Inc.
DescriptionLatanoprost delivered to the anterior chamber using Icon's Verisome drug delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today